Constitutive and Enhanced Expression from the CMV Major IE Promoter in a Defective Adenovirus Vector

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 1992 May 11

PMID 1317548

Citations 59

Authors

G W Wilkinson

A Akrigg

Affiliations

Soon will be listed here.

Abstract

A defective adenovirus (Ad) type 5 E1- vector has been combined with the powerful constitutive cytomegalovirus (CMV) major immediate early (IE) promoter to produce a novel eukaryotic expression system. The Ad vector can replicate to high titres in 293 cells and then be used to infect a wide variety of non-permissive cell types. The Escherichia coli lacZ and CMV IE1 genes have been cloned to generate the Ad recombinants RAd35 and RAd31 respectively. In human fibroblasts infected with RAd35 beta-galactosidase (beta-gal) expression could be detected in virtually 100% of target cells, there was no detectable transcription from the Ad genome and extremely high levels of expression could be achieved with beta-gal representing the predominant cytoplasmic cellular protein. Additionally, a number of agents, including the CMV IE1 gene product (in RAd31) and forskolin, significantly enhanced expression from RAd35-infected human fibroblasts. Lower levels of constitutive beta-gal expression were obtained in RAd35-infected HeLa cells but again expression could be enhanced (up to 60 fold) by chemical inducing agents. Expression from the IE promoter in the Ad vector could be repressed by coinfection with CMV.

Citing Articles

Inhibition of TGF-β signaling, invasion, and growth of cutaneous squamous cell carcinoma by PLX8394.

Siljamaki E, Riihila P, Suwal U, Nissinen L, Rappu P, Kallajoki M Oncogene. 2023; 42(49):3633-3647.

PMID: 37864034 PMC: 10691969. DOI: 10.1038/s41388-023-02863-8.

Super Enhancer-Regulated () Upregulates the Expression of MMP-1 and MMP-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma.

Piipponen M, Riihila P, Knuutila J, Kallajoki M, Kahari V, Nissinen L Cancers (Basel). 2022; 14(16).

PMID: 36010973 PMC: 9406669. DOI: 10.3390/cancers14163980.

Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge.

Gabitzsch E, Safrit J, Verma M, Rice A, Sieling P, Zakin L Front Immunol. 2021; 12:729837.

PMID: 34603305 PMC: 8481919. DOI: 10.3389/fimmu.2021.729837.

Design and Application of A Bioluminescent Biosensor for Detection Of Toxicity Using Huh7-CMV-Luc Cell Line.

Rahimirad N, Kavoosi S, Shirzad H, Sadeghizadeh M Iran J Pharm Res. 2019; 18(2):686-695.

PMID: 31531052 PMC: 6706743. DOI: 10.22037/ijpr.2019.1100687.

Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.

Dai B, Yan S, Lara-Guerra H, Kawashima H, Sakai R, Jayachandran G PLoS One. 2015; 10(6):e0123967.

PMID: 26053020 PMC: 4460038. DOI: 10.1371/journal.pone.0123967.

References

Rosenfeld M, Yoshimura K, Trapnell B, Yoneyama K, Rosenthal E, Dalemans W . In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 1992; 68(1):143-55. DOI: 10.1016/0092-8674(92)90213-v. View

Graham F, Smiley J, Russell W, Nairn R . Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977; 36(1):59-74. DOI: 10.1099/0022-1317-36-1-59. View

Cockett M, Bebbington C, Yarranton G . The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines. Nucleic Acids Res. 1991; 19(2):319-25. PMC: 333597. DOI: 10.1093/nar/19.2.319. View

Cherrington J, Khoury E, Mocarski E . Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site. J Virol. 1991; 65(2):887-96. PMC: 239829. DOI: 10.1128/JVI.65.2.887-896.1991. View

Liu B, Hermiston T, Stinski M . A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2. J Virol. 1991; 65(2):897-903. PMC: 239830. DOI: 10.1128/JVI.65.2.897-903.1991. View

Olive D, Simsek M, Zarban S, Al-Nakib W . The human cytomegalovirus immediate early enhancer-promoter is responsive to activation by the adenovirus-5 13S E1A gene. Arch Virol. 1990; 112(1-2):67-80. DOI: 10.1007/BF01348986. View

Chang Y, Crawford S, Stall J, Rawlins D, Jeang K, Hayward G . The palindromic series I repeats in the simian cytomegalovirus major immediate-early promoter behave as both strong basal enhancers and cyclic AMP response elements. J Virol. 1990; 64(1):264-77. PMC: 249099. DOI: 10.1128/JVI.64.1.264-277.1990. View

Stamminger T, Fickenscher H, Fleckenstein B . Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP. J Gen Virol. 1990; 71 ( Pt 1):105-13. DOI: 10.1099/0022-1317-71-1-105. View

Pizzorno M, Hayward G . The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site. J Virol. 1990; 64(12):6154-65. PMC: 248790. DOI: 10.1128/JVI.64.12.6154-6165.1990. View

10.

Spessot R, Inchley K, Hupel T, Bacchetti S . Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication. Virology. 1989; 168(2):378-87. DOI: 10.1016/0042-6822(89)90279-1. View

11.

Fickenscher H, Stamminger T, Ruger R, Fleckenstein B . The role of a repetitive palindromic sequence element in the human cytomegalovirus major immediate early enhancer. J Gen Virol. 1989; 70 ( Pt 1):107-23. DOI: 10.1099/0022-1317-70-1-107. View

12.

Gorman C, Gies D, McCray G, Huang M . The human cytomegalovirus major immediate early promoter can be trans-activated by adenovirus early proteins. Virology. 1989; 171(2):377-85. DOI: 10.1016/0042-6822(89)90605-3. View

13.

Sambucetti L, Cherrington J, Wilkinson G, Mocarski E . NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 1989; 8(13):4251-8. PMC: 401626. DOI: 10.1002/j.1460-2075.1989.tb08610.x. View

14.

LaFemina R, Hayward G . Differences in cell-type-specific blocks to immediate early gene expression and DNA replication of human, simian and murine cytomegalovirus. J Gen Virol. 1988; 69 ( Pt 2):355-74. DOI: 10.1099/0022-1317-69-2-355. View

15.

McGrory W, Bautista D, Graham F . A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 1988; 163(2):614-7. DOI: 10.1016/0042-6822(88)90302-9. View

16.

Akrigg A, Wilkinson G, ORAM J . The structure of the major immediate early gene of human cytomegalovirus strain AD169. Virus Res. 1985; 2(2):107-21. DOI: 10.1016/0168-1702(85)90242-4. View

17.

Sinclair J . The human cytomegalovirus immediate early gene promoter is a strong promoter in cultured Drosophila melanogaster cells. Nucleic Acids Res. 1987; 15(5):2392. PMC: 340646. DOI: 10.1093/nar/15.5.2392. View

18.

Gorman C, Howard B, Reeves R . Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acids Res. 1983; 11(21):7631-48. PMC: 326508. DOI: 10.1093/nar/11.21.7631. View

19.

Tanaka J, Sadanari H, Sato H, Fukuda S . Sodium butyrate-inducible replication of human cytomegalovirus in a human epithelial cell line. Virology. 1991; 185(1):271-80. DOI: 10.1016/0042-6822(91)90774-6. View

20.

Alp N, Allport T, van Zanten J, Rodgers B, Sissons J, Borysiewicz L . Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein. J Virol. 1991; 65(9):4812-20. PMC: 248939. DOI: 10.1128/JVI.65.9.4812-4820.1991. View